Cargando…
Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible
Despite the availability of antifibrotic therapies, many patients with idiopathic pulmonary fibrosis (IPF) will progress to advanced disease and require lung transplantation. International guidelines for transplant referral and listing of patients with interstitial lung disease are not specific to t...
Autores principales: | Balestro, Elisabetta, Cocconcelli, Elisabetta, Tinè, Mariaenrica, Biondini, Davide, Faccioli, Eleonora, Saetta, Marina, Rea, Federico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843894/ https://www.ncbi.nlm.nih.gov/pubmed/31635104 http://dx.doi.org/10.3390/medicina55100702 |
Ejemplares similares
-
The Role of the Lung’s Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis
por: Spagnolo, Paolo, et al.
Publicado: (2019) -
CA 19-9 serum levels in patients with end-stage idiopathic pulmonary
fibrosis (IPF) and other interstitial lung diseases (ILDs): Correlation with
functional decline
por: Balestro, Elisabetta, et al.
Publicado: (2020) -
High-Resolution CT Change over Time in Patients with Idiopathic Pulmonary Fibrosis on Antifibrotic Treatment
por: Balestro, Elisabetta, et al.
Publicado: (2019) -
Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis
por: Balestro, Elisabetta, et al.
Publicado: (2016) -
Heart Failure is Highly Prevalent and Difficult to Diagnose in Severe Exacerbations of COPD Presenting to the Emergency Department
por: Tinè, Mariaenrica, et al.
Publicado: (2020)